|
| 1 |
Discontinuing Denosumab: Can It Be Done Safely? A Review of the Literature
Wei Lin Tay, Donovan Tay
Endocrinol Metab.2022;37(2):183-194. Published online 2022 April 14
DOI: http://dx.doi.org/10.3803/EnM.2021.1369
|
|
| 2 |
Changes in Serum Dickkopf-1, RANK Ligand, Osteoprotegerin, and Bone Mineral Density after Allogeneic Hematopoietic Stem Cell Transplantation Treatment
Eunhee Jang, Jeonghoon Ha, Ki-Hyun Baek, Moo Il Kang
Endocrinol Metab.2021;36(6):1211-1218. Published online 2021 December 8
DOI: http://dx.doi.org/10.3803/EnM.2021.1248
|
|
| 3 |
Intravenous Immunoglobulin Controls Th17 Cell-Mediated Osteoclastogenesis
Kyoung-Woon Kim, Hae-Rim Kim, Bo-Mi Kim, Ji-Yeon Won, Kyung-Ann Lee, Sang-Heon Lee
Immune Netw.2019;19(4):e27. Published online 2019 August 6
DOI: http://dx.doi.org/10.4110/in.2019.19.e27
|
|
| 4 |
Fexaramine Inhibits Receptor Activator of Nuclear Factor-κB Ligand-induced Osteoclast Formation via Nuclear Factor of Activated T Cells Signaling Pathways
Ting Zheng, Na-Young Kim, Mijung Yim
J Bone Metab.2017;24(4):207-215. Published online 2017 November 30
DOI: http://dx.doi.org/10.11005/jbm.2017.24.4.207
|
|
| 5 |
Can denosumab be a substitute, competitor, or complement to bisphosphonates?
Su Young Kim, Hwoe Gyeong Ok, Christof Birkenmaier, Kyung Hoon Kim
|
|
| 6 |
Osteoclasts: Crucial in Rheumatoid Arthritis
Won-Ju Jeong, Ha-Jeong Kim
J Rheum Dis.2016;23(3):141-147. Published online 2016 October 31
DOI: http://dx.doi.org/10.4078/jrd.2016.23.3.141
|
|
| 7 |
Signaling Pathways in Osteoclast Differentiation
Jung Ha Kim, Nacksung Kim
Chonnam Med J.2016;52(1):12-17. Published online 2016 January 19
DOI: http://dx.doi.org/10.4068/cmj.2016.52.1.12
|
|
| 8 |
Peri-implant crevicular fluid levels of cathepsin-K, RANKL, and OPG around standard, short, and mini dental implants after prosthodontic loading
Raif Alan, İsmail Marakoğlu, Seyfullah Haliloğlu
|
|
| 9 |
NF-κB-Mediated Regulation of Osteoclastogenesis
Brendan F. Boyce, Yan Xiu, Jinbo Li, Lianping Xing, Zhenqiang Yao
|
|
| 10 |
Effect of recombinant human bone morphogenetic protein-2 on bisphosphonate-treated osteoblasts
Taek-Kyun Kwon, Jae-Min Song, In-Ryoung Kim, Bong-Soo Park, Chul-Hoon Kim, In-Kyo Cheong, Sang-Hun Shin
|
|
| 11 |
Regulation of NFATc1 in Osteoclast Differentiation
Jung Ha Kim, Nacksung Kim
J Bone Metab.2014;21(4):233-241. Published online 2014 November 30
DOI: http://dx.doi.org/10.11005/jbm.2014.21.4.233
|
|
| 12 |
Methanol Extract of Croton Pycnanthus Benth. Inhibits Osteoclast Differentiation by Suppressing the MAPK and NF-κB Signaling Pathways
Jiyeon Lee, Hong-Hee Kim
J Bone Metab.2014;21(4):269-275. Published online 2014 November 30
DOI: http://dx.doi.org/10.11005/jbm.2014.21.4.269
|
|
| 13 |
Mouse Models for the Evaluation of Osteocyte Functions
Toshihisa Komori
J Bone Metab.2014;21(1):55-60. Published online 2014 February 28
DOI: http://dx.doi.org/10.11005/jbm.2014.21.1.55
|
|
| 14 |
Salivary soluble receptor activator of nuclear factor kappa B ligand/osteoprotegerin ratio in periodontal disease and health
Zahra Alizadeh Tabari, Abbas Azadmehr, Mohammad Amir Alizadeh Tabrizi, Jalaloddin Hamissi, Fatemeh Baharak Ghaedi
|
|
| 15 |
Cellular Localization of RANKL and RANK Production in Giant Cell Tumors of Bone and Tendon Sheath by Immunohistochemistry
Ha Rin Cheong, Hanna Kang, Dong Eun Song, Min-Sun Cho
Ewha Med J.2010;33(1):23-28. Published online 2010 March 31
DOI: http://dx.doi.org/10.12771/emj.2010.33.1.23
|
|
